×
ADVERTISEMENT

ensartinib

FDA Approves Ensacove for ALK-Positive Locally Advanced or Metastatic NSCLC

The FDA approved Ensacove for adult patients with anaplastic lymphoma kinase (ALK)-positive locally advanced or ...

DECEMBER 19, 2024

Load more